JOHNSON & JOHNSON JNJ 69.32
Health Care · NYSE · Data as of 2026-07-23
JOHNSON & JOHNSON (JNJ) has delivered +2.2% annualized revenue growth, +17.1% earnings growth, and +4.2% dividend growth over 10 years of data. Ranked #284 of 1993 stocks overall and #30 of 264 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
69.32
Overall Rank
#284 / 1993
Sector Rank
#30 / 264
Revenue CAGR
+2.2%
Earnings CAGR
+17.1%
Dividend CAGR
+4.2%
?
E/R CAGR Ratio
7.8x
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio